Business Description
Codiak BioSciences Inc
NAICS : 541714
SIC : 2833
Share Class Description:
CDAKQ: Ordinary SharesCompare
Compare
Traded in other countries / regions
32W.Germany IPO Date
2020-10-14Description
Codiak BioSciences Inc is a development-stage biopharmaceutical company focused on the development of exosome-based therapeutics for the treatment of a wide spectrum of diseases with high unmet medical need. The company have utilized engEx Platform to generate a pipeline of engineered exosomes, aimed at treating a broad range of diseases, including oncology, neuro-oncology, neurology, neuromuscular disease, infectious disease and rare disease.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 29.43 | |||||
| 9-Day RSI | 33.99 | |||||
| 14-Day RSI | 36.93 | |||||
| 6-1 Month Momentum % | -97.67 | |||||
| 12-1 Month Momentum % | -99.56 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | -201.86 |
GF Value Rank
| Name | Current | Vs Industry | Vs History |
|---|
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:CDAKQ
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Codiak BioSciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 33.574 | ||
| EPS (TTM) ($) | -0.69 | ||
| Beta | 0 | ||
| Volatility % | 149.27 | ||
| 14-Day RSI | 36.93 | ||
| 14-Day ATR ($) | 0.00423 | ||
| 20-Day SMA ($) | 0.006771 | ||
| 12-1 Month Momentum % | -99.56 | ||
| 52-Week Range ($) | 0.0016 - 3.26 | ||
| Shares Outstanding (Mil) | 36.83 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Codiak BioSciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Codiak BioSciences Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Codiak BioSciences Inc Frequently Asked Questions
What is Codiak BioSciences Inc(CDAKQ)'s stock price today?
The current price of CDAKQ is $0.00. The 52 week high of CDAKQ is $3.26 and 52 week low is $0.00.
When is next earnings date of Codiak BioSciences Inc(CDAKQ)?
The next earnings date of Codiak BioSciences Inc(CDAKQ) is 2024-08-04 Est..
Does Codiak BioSciences Inc(CDAKQ) pay dividends? If so, how much?
Codiak BioSciences Inc(CDAKQ) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers